Sign in
CompletedPhase 3

Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32)

Key facts

Who runs it
Bioaraba Health Research Institute
Where
Spain9 sites in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 3
People taking part
390 people enrolled
Started
7 Oct 2022
Ended
1 Oct 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • N-acetylcysteine
Record updated
16 October 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Men and women
  • Age from 18 to 75 years
  • Patients with acute alcoholic hepatitis according to AASLD criteria or compatible liver histology
  • Maddrey score> = 32
  • Acceptance of participation through written informed consent

Who cannot take part

  • Concomitant uncontrolled diseases (HBV, HCV, HIV, TB, DILI, HCC or acute pancreatitis)
  • Any cause of jaundice: acute hepatitis, positive HIV serology, biliary-pancreatic pathology, hemolytic anemia
  • Allergy or intolerance to N-acetylcysteine and / or corticosteroids
  • Any disease whose life expectancy is less than 12 months
  • Patients with uncontrolled active infection
  • Uncontrolled upper gastrointestinal bleeding
  • Multiple organ failure or shock
  • Acute kidney disease with creatinine> 2.5 mg / dL
  • Hepatocarcinoma
  • Portal cavernomatosis
  • Portal cavernomatosis
  • Patients with nitroglycerin and / or carbamazepine-based treatments

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is designed to evaluate the hypothesis that patients with severe acute alcoholic hepatitis have lower morbi-mortality if the patients receive treatment with corticosteroids + NAC, compared to patients that only receive corticosteroids.

The 2 groups in the trial

  • CorticosteroidsExisting treatment, for comparison

    Corticosteroids following Standard Clinical Practice

    Treatment: N-acetylcysteine

  • Corticosteroids + N-acetylcysteineTreatment being tested

    Corticosteroids following Standard Clinical Practice plus N-acetylcisteine

    Treatment: N-acetylcysteine

Data and sources

Registry record
Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
16 October 2026